Clinical Trials Directory

Trials / Completed

CompletedNCT01651611

Intervention Study to Increase Smoking Cessation Rates Among Public Housing Residents

Health Advocates as a Vehicle to Improve Treatment for Smokers in Public Housing

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
330 (actual)
Sponsor
Boston University · Academic / Other
Sex
All
Age
18 Years – 79 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine whether public housing residents trained in Tobacco Cessation and Motivational Interviewing Techniques to become Tobacco Treatment Advocates(TTA) will be effective in increasing the quit rate of smokers in Boston Public Housing. The investigators hypothesize that smokers that receive multiple TTA visits will be more likely to (1) use smoking cessation resources and (2) quit compared to smokers who receive a single visit.

Detailed description

The study is a group-randomized trial in which 10 pubic housing developments (PHDs) are randomized to the experimental condition and 10 to the control condition. All smokers who enroll in the study at a particular PHD receive the same intervention. Smokers at control sites receive written materials that offer strategies for quitting and information about availability of treatment programs, as well as a one-time meeting with a Tobacco Treatment Advocate (TTA). The intervention group receives the same written materials but also has much more extensive interactions with a TTA. TTAs provide peer counseling (Peer Counseling is defined as: performance of limited counselor functions, under counselor supervision, by person of similar age,gender, race, ethnicity and/or SES of the counselee) to smokers during in- person Motivational Enhancement meetings (target range 7-9) as well as additional in person and phone contacts, as needed for each participant, over a 6-month period. TTAs receive intensive training in motivational interviewing and smoking cessation counseling deliver the intervention components (counseling activities and provision of environmental supports) in addition to encouraging utilization of smoking cessation treatment programs such as the Smokers' QuitLine (SQL) and clinic-based programs. In order to avoid the potential for contamination due to TTAs interacting with participants at both intervention and control sites, meetings with participants at control sites are conducted by special Control TTAs. Data are collected from study participants at baseline, 3 months, 7 months and 12 months, and also from the SQL and clinics.

Conditions

Interventions

TypeNameDescription
BEHAVIORALMotivational interviewingThe TTA will use motivational interviewing (MI) techniques to assess the participant's motivation and readiness to quit, suggest plans, and assist the participant in selecting a method of treatment.
BEHAVIORALSmoking cessation counselingThe TTA will provide information to the participant regarding evidence-based treatments for smoking cessation, including counseling and nicotine replacement therapy (NRT); assist in a quit plan; and discuss issues such as obtaining social support, staying in treatment, and dealing with lapses.
BEHAVIORALNavigation to smoking cessation resourcesThe TTA will assist participants in obtaining NRT and getting connected to smoking cessation counseling services, such as the Smokers' Quitline and clinic-based programs.
BEHAVIORALSocial supportMeetings with the TTA will be a source of social support for the participant as they attempt to quit or stay quit.

Timeline

Start date
2011-09-01
Primary completion
2014-09-01
Completion
2014-09-01
First posted
2012-07-27
Last updated
2016-08-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01651611. Inclusion in this directory is not an endorsement.